Clinical, serologic, and-immunogenetic features in polish patients with idiopathic inflammatory myopathies

Arthritis and Rheumatism

Volumn 40, Issue 7, 1997, Pages 1257-1266

  Hausmanowa Petrusewicz, Irena ^a,e   Kowalska Olȩdzka, Elzbieta ^a   Miller, Frederick W ^b   Jarza̧bek Chorzelska, Maria ^c   Targoff, Ira N ^d   Blaszczyk Kostanecka, Maria ^c   Jablonska, Stefania ^c  

^a POLISH ACADEMY OF SCIENCES   (Poland)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^e MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; DNA; HLA DQ ANTIGEN; HLA DR ANTIGEN; SYNTHETASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; HAPLOTYPE; HUMAN; HUMAN CELL; IMMUNODIFFUSION; IMMUNOFLUORESCENCE; IMMUNOGENETICS; MAJOR CLINICAL STUDY; MALE; MYOPATHY; MYOSITIS; ONSET AGE; POLAND; POLYMYOSITIS; PRIORITY JOURNAL; SEROLOGY;

EID: 1842333255     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199707)40:7<1257::AID-ART10>3.0.CO;2-R     Document Type: Article

References (71)

1. Bohan A, Peter JB: Polymyositis and dermatomyositis (parts I and II). N Engl J Med 292:344-347, 403-407, 1975
2. Plotz PH, Dalakas M, Leff RL, Love LA, Miller FW, Cronin ME: Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders. Ann Intern Med 111:143-157, 1989
3. Dalakas M: Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 325:1487-1498, 1991
4. Miller FW: Myositis specific autoantibodies: touchstones for understanding the inflammatory myopathies. JAMA 270:1846-1849, 1993
5. Miller FW: Humoral immunity and immunogenetics in the idiopathic inflammatory myopathies. Curr Opin Rheumatol 3:902-910, 1991
6. Targoff IN: Humoral immunity in polymyositis/dermatomyositis. Arthritis Rheum 28:796-803, 1985
7. Targoff IN: Autoantibodies in polymyositis. Rheum Dis Clin North Am 18:455-482, 1992
8. Love LA, Miller FW: Noninfectious environmental agents associated with myopathies. Curr Opin Rheumatol 5:712-718, 1993
9. Nishikai M, Reichlin M: Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis: characterization of the Jo-1 antibody system. Arthritis Rheum 23:881-888, 1980
10. Targoff IN, Reichlin M: Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity. J Immunol 138:2874-2882, 1987
11. Miller FW, Waite KA, Biswas T, Plotz PH: The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity. Proc Natl Acad Sci U S A 87:9983-9987, 1990
12. Leff RL, Burgess SH, Miller FW, Love LA, Targoff IN, Dalakas MC, Joffe MM, Plotz PH: Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies. Arthritis Rheum 34:1391-1396, 1991
13. Engel AG, Hohlfeld R, Banker BQ: The polymyositis and dermatomyositis syndromes. In, Myology. Edited by AG Engel, BQ Banker. New York, McGraw-Hill, 1994
14. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW: A new approach to the classification of idiopathic inflammatory myopathy: myositis specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 34: 1391-1396, 1991
15. Tan EM: Antinuclear antibodies: diagnostic markers tor autoimmune diseases and probes for cell biology. Adv Immunol 44:93-151, 1989
16. Sontheimer RD, McCauliffe DP, Zappi E, Targoff IN: Antinuclear antibodies: clinical correlations and biologic significance. Adv Dermatol 7:3-42, 1991
17. Mathews MB, Bernstein RM: Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature 304:177-179, 1983
18. Targoff IN, Arnett FC, Reichlin M: Antibody to threonyl-transfer RNA synthetase in myositis sera. Arthritis Rheum 31:513-524, 1988
19. Mathews MB, Reichlin M, Hughes GRV, Bernstein RM: Antithreonyl-tRNA synthetase, a second myositis related autoantibody. J Exp Med 160:420-434, 1984
20. Targoff IN, Arnett FC: Clinical manifestation in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med 88:241-251, 1990
21. Bunn CC, Bernstein RM, Mathews MB: Autoantibodies against alanyl-tRNA synthetase and tRNA coexist and are associated with myositis. J Exp Med 163:1281-1291, 1986
22. Targoff IN, Trieu EP, Plotz PH, Miller FW: Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease. Arthritis Rheum 35:821-830, 1992
23. Targoff IN: Autoantibodies to aminoacyl-tRNA synthetases for isoleucine and glycine: two additional synthetases are antigenic in myositis. J Immunol 144:1737-1743, 1990
24. Bernstein RM, Morgan SH, Chapman J, Bunn CC, Mathews MB, Turner-Warwick M, Hughes GRV: Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. BMJ 289:151-152, 1984
25. Phillips TJ, Leigh IM, Wright J: Dermatomyositis and pulmonary fibrosis associated with anti-Jo-1 antibody. J Am Acad Dermatol 17:381-382, 1987
26. Targoff IN: Laboratory manifestations in polymyositis/dermatomyositis. Clin Dermatol 6:76-92, 1988
27. Targoff IN, Reichlin M: Immunological aspects. In, Inflammatory Disease of the Muscle. Edited by FL Mastaglia. Oxford, Blackwell Scientific, 1988
28. Jablonska S, Chorzelski TP, Blaszczyk M, Jarzabek-Chorzelska M, Kumar V, Beutner EH: Scleroderma/polymyositis overlap syndromes and their immunologic markers. Clin Dermatol 10:457-472, 1993
29. Targoff IN, Johnson AE, Miller FW: Antibody to signal recognition particle in polymyositis. Arthritis Rheum 33:1361-1370, 1990
30. Okada N, Mimori T, Mukai R, Kashiwagi H, Hardin JA: Characterization of human autoantibodies that selectively precipitate the 7SL RNA component of the signal recognition particle. J Immunol 138:3219-3223, 1987
31. Hirakata M, Mimori T, Akizuki M, Craft J, Hardin JA, Homma M: Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum 35:449-456, 1992
32. Seelig HP, Moosbrugger I, Ehrfeld H, Fink T, Renz M, Genth E: The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation. Arthritis Rheum 38:1389-1399, 1995
33. Targoff IN, Reichlin M: The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum 28:796-803, 1985
34. Nilasena DS, Trieu EP, Targoff IN: Analysis of the Mi-2 autoantigen of dermatomyositis. Arthritis Rheum 38:123-128, 1995
35. Targoff IN, Reichlin M: Nucleolar localization of the PM-Scl antigen. Arthritis Rheum 28:226-230, 1985
36. Reichlin M, Arnett FC Jr: Multiplicity of antibodies in myositis sera. Arthritis Rheum 27:1150-1156, 1984
37. Ge Q, Wu Y, Trieu EP, Targoff IN: Analysis of the specificity of anti-PM-Scl autoantibodies. Arthritis Rheum 37:1445-1452, 1994
38. Ge Q, Frank MB, O'Brien CA, Targoff IN: Cloning of a complementary DNA coding for the 100-kD antigenic protein of the PM-Scl autoantigen. J Clin Invest 90:559-570, 1992
39. Yaneva M, Arnett FC: Antibodies against Ku protein in sera from patients with autoimmune diseases. Clin Exp Immunol 76:366-372, 1989
40. Reeves WH, Pierani A, Chou C-H: Epitopes of the p 70 and 80 (Ku) lupus autoantigens. J Immunol 146:2678-2686, 1991
41. Porges AJ, Ng T, Reeves WH: Antigenic determinants of the Ku (p70/p80) autoantigen are poorly conserved between species. J Immunol 145:4222-4228, 1990
42. Mimori T, Hardin JA: Mechanism of interaction between Ku protein and DNA. J Biol Chem 261:10375-10379, 1986
43. Isern RA, Yaneva M, Weiner E, Parke A, Rothfield N, Dantzker D, Rich S, Arnett FC: Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku. Am J Med 93:307-312, 1992
44. Reichlin M, Maddison PJ, Targoff IN, Bunch T, Arnett FC, Sharp GC, Treadwell EL, Tan EM: Antibodies to nuclear/nucleolar antigen in patients with polymyositis overlap syndromes. J Clin Immunol 4:40-44, 1984
45. Reimer G, Steen VD, Penning CA, Medsger TA Jr, Tan EM: Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum 31:525-532, 1988
46. Blaszczyk M, Jablonska S, Szymańska-Jagiello W, Jarzabek-Chorzelska M, Chorzelski TP, Mohamed AH: Childhood scleromyositis: an overlap syndrome associated with PM-Scl antibody. Pediatr Dermatol 8:1-8, 1991
47. Blaszczyk M, Jablonska S, Szymańska-Jagiello W, Jarzabek-Chorzelska M, Chorzelski TP: Immunologic markers of systemic scleroderma in children. Pediatr Dermatol 8:13-20, 1991
48. Blaszczyk M, Jarzabek-Chorzelska M, Jablonska S, Chorzelski T, Kolacinska-Strasz Z, Beutner EH, Kumar V: Autoantibodies to nucleolar antigens in systemic scleroderma: clinical correlations. Br J Dermatol 123:421-430, 1990
49. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HL: Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52:148-159, 1972
50. Kumar V, Beutner EH, Dabski K, Steger R, Koelle M: A standardized method of detecting antibodies to extractable nuclear antigens (RNP and Sm) by gel precipitation. J Clin Lab Immunol 15:163-166, 1984
51. Saito E, Yoshimoto Y, Oshima H, Yoshida H, Kinoshita M: Fluorescent antibodies in polymyositis using cultured human skin fibroblasts: granular perinuclear cytoplasmic staining pattern by sera from patients with polymyositis and pulmonary fibrosis. J Rheumatol 16:47-54, 1989
52. Yoshida S, Akizuki M, Mimori T, Yamagata H, Inada S, Homma M: The precipitating antibody to an acidic nuclear protein antigen the Jo-1, in connective tissue diseases: a marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum 26:604-611, 1983
53. Reimer G, Steen VD, Penning CA, Medsger TA Jr, Tan EM: Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum 31:525-532, 1988
54. Targoff IN, Arnett FC, Berman L, O'Brien C, Reichlin M: Anti-KJ: a new antibody associated with the syndrome of polymyositis and interstitial lung disease. J Clin Invest 84:162-172, 1989
55. Ehrlich H, Bugawan T, Begovich AB, Scharf S, Griffith R, Saiki R, Higuchi R, Walsh PS: HLA-DR, DQ and DP typing using PCR amplification and immobilized probes. Eur J Immunogenet 18:33-55, 1991
56. Shi Y, Zou M, Robb D, Farid N: Typing for major histocompatibility complex class II antigens in thyroid tissue blocks: association of Hashimoto's thyroiditis with HLA-DQA1*0301 and HLA DQB1*0201 alleles. J Clin Endocrinol Metab 75:943-946, 1992
57. Gurley RC, Love LA, Targoff IN, Leff RL, Plotz PH, Miller FW: Associations among myositis-specific autoantibodies and HLA-DQA1 alleles (abstract). Arthritis Rheum 34 (suppl 9):S137, 1991
58. Plotz PH, Rider LG, Targoff IN, Raben N, O'Hanlon TP, Miller FW: NIH conference - myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med 122:715-724, 1995
59. Lee JE, Reveille JD, Ross MI, Platsoucas CD: HLA-DQB1*0301 association with increased melanoma risk. Int J Cancer 59:510-513, 1994
60. Matej H, Nowakowska B, Pacynska J, Kalamarz M, Baldy-Chudzik K, Bisikiewicz R: HLA-A, B, C and DR gene and haplolype frequencies in 600 Poles by maximum likelihood method of gene counting. Arch Immunol Ther Exp (Warsz) 40:151-156, 1992
61. Arnett FC, Goldstein R, Duvic M, Reveille JD: Major histocompatibility complex genes in systemic lupus erythematosus, Sjögren's syndrome, and polymyositis. Am J Med 85:38-41, 1988
62. Garlepp MJ, Laing B, Zilko PJ, Mastaglia FL: HLA associations with inclusion body myositis. Clin Exp Immunol 98:40-45, 1994
63. Garlepp MJ: Immunogenetics of inflammatory myopathies. Baillieres Clin Neurol 2:579-597, 1993
64. Miller FW: Genetics of autoimmune diseases. Exp Clin Immunogenet 12:182-190, 1995
65. Marguerie C, Bunn CC, Copier J, Bernstein RM, Gilroy JM, Black CM, So AK, Walport MJ: The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl. Medicine (Baltimore) 71:321-335, 1992
66. Oddis CV, Okano Y, Rudert WA, Trucco M, Duquesnoy RJ, Medsger TA Jr: Serum autoantibody to the nucleolar antigen PM-Scl: clinical and immunogenetic associations. Arthritis Rheum 35:1211-1217, 1992
67. Goldstein R, Duvic M. Targoff IN, Reichlin M, McMenemy AM, Reveille JD, Warner NB, Pollack MS. Arnett FC: HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis. Arthritis Rheum 33:1240-1248, 1990
68. Reimer G, Scheer U, Peters JM: Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis/scleroderma overlap syndromes. J Immunol 137:3802-3808, 1986
69. Hausmanowa-Petrusewicz I, Jablonska S, Blaszczyk M, Drac H, Roninska K, Emeryk B, Ryniewicz B, Kopec A, Szmidt D, Raszewa M, Zakrzewska B, Karwaska A: Neuromuscular involvement in various subsets of scleroderma as related to immune markers. In, Systeme Nerveaux, Muscles et Maladies Systemiques: Acquisitions Recentes. Edited by G Serratrice, JF Pellissier, J Pouget. Expansion Scientifique Francaise, 1993
70. Hausmanowa-Petrusewicz I, Blaszczyk M, Kowalska E, Rowinska K, Zakrzewska B, Drac H, Jablonska S: Neuromuscular studies in scleromyositis. Acta Cardiomiol 6:99-110, 1994
71. Alarcon-Segovia D, Cardiel MM: Comparison between 3 diagnostic criteria for mixed connective tissue disease: study of 593 patients. J Rheumatol 16:328-334, 1989